Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Overall Survival of Patients Diagnosed With Unresectable Hepatocellular Carcinoma Under Real-life Clinical Practice in Asia Pacific Region

NCT03612726 is registered in ClinicalTrials.gov with Humanity & Health Medical Group Limited as lead sponsor.

NCT NCT03612726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03612726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Overall Survival of Patients Diagnosed With Unresectable Hepatocellular Carcinoma Under Real-life Clinical Practice in Asia Pacific Region
Lead sponsor
Humanity & Health Medical Group Limited
Phase
Observational
Overall status
Recruiting
Start date
July 16, 2018
Completion date
December 31, 2025
Enrollment
5,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma